Professor of Obstetrics and Gynecology, Ohio State University
Obstetrics & Gynecology
Dr. Larry J. Copeland, MD
|
|
Give Review
Larry Copeland practices Obstetrics & Gynecology. He has 5 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Fellow (FACOG)" and "Fellow (FACS)". Larry Copeland is a published doctor and has 37 publications published. The lastest was: 'Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Survival outcomes of obese patients in type II endometrial Cancer: Defining the prognostic impact of increasing BMI.
- Setting the bar: compliance with ovarian Cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
- The Use of Transvaginal Ultrasound in Type II Endometrial Cancer.
- Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated Cervical, vaginal, or vulvar cancer?
- Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
- A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian Cancer.
- Severe pegfilgrastim-induced bone Pain completely alleviated with loratadine: A case report.
- Feasibility of Interval Cytoreduction Following Neoadjuvant Chemotherapy With Carboplatin, Weekly Paclitaxel, and Bevacizumab for Advanced Ovarian Cancer-A Phase 1 Study.
- Ovarian Cancer, version 2.2013.
- Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian Cancer?
- Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian Cancer.
- The impact of close surgical margins after radical hysterectomy for early-stage Cervical cancer.
- Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian Cancer.
- Point: chemosensitivity assays have a role in the management of recurrent ovarian Cancer.
- Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial Cancer.
- Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian Cancer.
- Prospective evaluation of DNA mismatch repair protein expression in primary endometrial Cancer.
- Reclassification of leiomyosarcoma as an extra-gastrointestinal stromal tumor of the gynecologic Tract.
- Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenoCarcinoma.
- Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian Cancer.
- CA125 decline in ovarian Cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.
- The Society of Gynecologic Oncologists: yesterday, today and tomorrow.
- Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian Cancer.
- Improved survival with an intact DNA mismatch repair system in endometrial Cancer.
- Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian Cancer.
- Case report: malignant peritoneal mesothelioma in two siblings.
- Implications of second-look laparotomy in the context of optimally resected stage III ovarian Cancer: a non-randomized comparison using an explanatory analysis: a Gyne...
- Invasive cervical adenoCarcinoma immediately following a cone biopsy for adenoCarcinoma in situ with negative margins.
- Surgical staging for patients presenting with grade 1 endometrial Carcinoma.
- Morbid obesity and endometrial Cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.
- Borderline Ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.
- The ethics of reporting and disseminating results of clinical research trials.
- Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial Cancer?
- Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertica...
- Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial Cancer patients.
- Ureteroileoneocystostomy: the use of an ileal segment for ureteral substitution in gynecologic oncology.
Schools
Schulich School Of Medicine At The University Of Western Ontario
McMaster University
MD Anderson Hospital Tum Institute
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- Dilation and Curettage
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Chronic Pelvic Pain
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Medical Mutual of Ohio POS
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FACOG)
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of Western Ontario
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1477595510 | |
| NPPES Provider LastName | COPELAND | |
| NPPES Provider FirstName | LARRY | |
| NPPES Provider ZIPCode | 430267752 | |
| NPPES Provider State | OH | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 85.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477595510 |
| Last Name Of The Provider | COPELAND |
| First Name Of The Provider | LARRY |
| View All |
Similar Doctors
|
Dr. Esberdado S. Villanueva, MD |
|
Dr. Gary C. Reid, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey M. Fowler, MD |
|
|
Dr. Fred M. Abramovitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey G. Bell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wiley G. Woodard, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kellie Rath, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicole M. Book, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. O'Malley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Luis Vaccarello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey L. Cacchio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell W. Spahn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David E. Cohn, MD |
|
|
Dr. Elaine A. Paul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara M. Rood, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jacqueline T. Rohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian M. Becher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney A. Abshier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pablo A. Pons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silpa Nekkanti, MD
This Doctor is OpenDoctor Recommended.
|